Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.42 SEK | -1.46% | -4.66% | -16.04% |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 | |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 |
Sales 2024 * | 580M 53.27M | Sales 2025 * | 620M 56.98M | Capitalization | 366M 33.61M |
---|---|---|---|---|---|
Net income 2024 * | 28M 2.57M | Net income 2025 * | 41M 3.77M | EV / Sales 2024 * | 0.77 x |
Net Debt 2024 * | 77.93M 7.16M | Net Debt 2025 * | 75.63M 6.95M | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
12.7
x | P/E ratio 2025 * |
8.74
x | Employees | 228 |
Yield 2024 * |
2.18% | Yield 2025 * |
3.61% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | -1.46% | ||
1 week | -4.66% | ||
Current month | -5.14% | ||
1 month | -5.33% | ||
3 months | -13.89% | ||
6 months | -0.21% | ||
Current year | -16.04% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | Dec. 31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 9.42 | -1.46% | 19,433 |
24-04-24 | 9.56 | -1.44% | 1,521 |
24-04-23 | 9.7 | +0.83% | 2,928 |
24-04-22 | 9.62 | -2.43% | 14,206 |
24-04-19 | 9.86 | -0.20% | 3,085 |
Delayed Quote Nasdaq Stockholm, April 25, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.04% | 33.54M | |
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.57% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |
- Stock Market
- Equities
- BOUL Stock